Regenxbio (RGNX) FCF Margin (2014 - 2026)
Regenxbio's FCF Margin was -58.32% in Q2 2026, up 174.52 percentage points from -232.84% a year earlier and up 1152.71 percentage points from the prior quarter.
Powered by 
Analysis
Regenxbio (RGNX) FCF Margin (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Regenxbio's FCF Margin was -143.09% through Jun 30, 2026, down 84.86 percentage points year-over-year; for FY2025, it was -74.15%, up 136.54 percentage points from FY2024.
- FCF Margin shows a five-year change of -21.79 percentage points (FY2020 to FY2025).
- In earlier years, FCF Margin was -210.69% in FY2024 (+42.37 pp), -253.06% in FY2023 (-41.74 pp), -211.32% in FY2022 (-239.96 pp) and 28.64% in FY2021 (+81.00 pp).
- The Q2 2026 figure marks the highest quarterly FCF Margin since Q1 2025.
- Compared with a year earlier, FCF Margin was higher in four of the last eight quarters, with an average year-over-year change of -88.01 percentage points.
- The best year-over-year quarter for FCF Margin over five years was Q1 2025 (a gain of 395.18 percentage points); the worst was Q1 2026 (a drop of 1247.66 percentage points).
- Per Business Quant data, RGNX's FCF Margin in the three quarters before Q2 2026 was -1211.03% (Q1 2026), -174.04% (Q4 2025) and -189.86% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 28.96% |
| 10 | Regenxbio | 508.48 Mn | -228.57 Mn | - | 419.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 419.29% |
| Jun 30, 2026 | -58.32% |
| Mar 31, 2026 | -1,211.03% |
| Dec 31, 2025 | -174.04% |
| Sep 30, 2025 | -189.86% |
| Jun 30, 2025 | -232.84% |
| Mar 31, 2025 | 36.63% |
| Dec 31, 2024 | -154.16% |
| Sep 30, 2024 | -168.93% |
| Jun 30, 2024 | -206.19% |
| Mar 31, 2024 | -358.55% |
| Dec 31, 2023 | -188.57% |
| Sep 30, 2023 | -175.85% |
| Jun 30, 2023 | -249.78% |
| Mar 31, 2023 | -447.99% |
| Dec 31, 2022 | -143.06% |
| Sep 30, 2022 | -209.36% |
| Jun 30, 2022 | -217.42% |
| Mar 31, 2022 | -301.01% |
| Dec 31, 2021 | 82.00% |
API Access
Regenxbio FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();